FHLC vs. ARKG
FHLC (Fidelity MSCI Health Care Index ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both Health & Biotech Equities funds. FHLC is passively managed, while ARKG is actively managed. Over the past 10 years, FHLC returned 9.14%/yr vs 7.22%/yr for ARKG. A 0.62 correlation means they provide meaningful diversification when combined. FHLC charges 0.08%/yr vs 0.75%/yr for ARKG.
Performance
FHLC vs. ARKG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FHLC achieves a -3.90% return, which is significantly lower than ARKG's 17.09% return. Over the past 10 years, FHLC has outperformed ARKG with an annualized return of 9.14%, while ARKG has yielded a comparatively lower 7.22% annualized return.
FHLC
- 1D
- 0.82%
- 1M
- 1.50%
- YTD
- -3.90%
- 6M
- -4.11%
- 1Y
- 14.43%
- 3Y*
- 6.14%
- 5Y*
- 4.50%
- 10Y*
- 9.14%
ARKG
- 1D
- -0.24%
- 1M
- 10.92%
- YTD
- 17.09%
- 6M
- 10.02%
- 1Y
- 53.35%
- 3Y*
- 0.67%
- 5Y*
- -15.72%
- 10Y*
- 7.22%
FHLC vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FHLC Fidelity MSCI Health Care Index ETF | -3.90% | 15.42% | 2.48% | 2.58% | -5.55% | 20.39% | 18.13% | 21.94% | 4.71% | 23.34% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 17.09% | 23.04% | -28.24% | 16.22% | -53.90% | -33.92% | 180.40% | 44.00% | -1.26% | 46.61% |
Correlation
The correlation between FHLC and ARKG is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.51 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.53 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.57 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.61 |
Correlation (All Time) Calculated using the full available price history since Nov 3, 2014 | 0.62 |
The correlation between FHLC and ARKG shifts across timeframes, from 0.51 (1 year) to 0.62 (all time), reflecting how their relationship changes across market environments.
FHLC vs. ARKG - Sectors Allocation Comparison
Sectors
FHLC
ARKG
Healthcare
Financial Services
Technology
-
Industrials
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
FHLC
ARKG
Financial Services
FHLC
ARKG
Technology
FHLC
ARKG
-
Industrials
FHLC
ARKG
-
Basic Materials
FHLC
-
ARKG
-
Communication Services
FHLC
-
ARKG
-
Consumer Cyclical
FHLC
-
ARKG
-
Consumer Defensive
FHLC
-
ARKG
-
Energy
FHLC
-
ARKG
-
Real Estate
FHLC
-
ARKG
-
Utilities
FHLC
-
ARKG
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FHLC vs. ARKG — Risk / Return Rank
FHLC
ARKG
FHLC vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity MSCI Health Care Index ETF (FHLC) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FHLC | ARKG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.29 | ||
| Sortino ratioReturn per unit of downside risk | -0.41 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.22 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 1.40 | 1.95 | -0.55 |
| Martin ratioReturn relative to average drawdown | 3.52 | 4.67 | -1.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FHLC | ARKG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.01 | 1.31 | -0.29 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.30 | -0.35 | +0.65 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.55 | 0.18 | +0.37 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.61 | 0.13 | +0.47 |
Drawdowns
FHLC vs. ARKG - Drawdown Comparison
The maximum FHLC drawdown since its inception was -28.76%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for FHLC and ARKG.
Loading charts...
Drawdown Indicators
| FHLC | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -28.76% | -83.59% | +54.83% |
Max Drawdown (1Y)Largest decline over 1 year | -10.38% | -27.51% | +17.13% |
Max Drawdown (3Y)Largest decline over 3 years | -16.87% | -51.96% | +35.09% |
Max Drawdown (5Y)Largest decline over 5 years | -17.73% | -80.18% | +62.45% |
Max Drawdown (10Y)Largest decline over 10 years | -28.76% | -83.59% | +54.83% |
Current DrawdownCurrent decline from peak | -6.96% | -69.65% | +62.69% |
Average DrawdownAverage peak-to-trough decline | -5.19% | -35.87% | +30.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.11% | 11.46% | -7.35% |
Volatility
FHLC vs. ARKG - Volatility Comparison
The current volatility for Fidelity MSCI Health Care Index ETF (FHLC) is 4.05%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 11.90%. This indicates that FHLC experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FHLC | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.05% | 11.90% | -7.85% |
Volatility (6M)Calculated over the trailing 6-month period | 10.11% | 28.77% | -18.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.33% | 41.12% | -26.79% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.97% | 45.61% | -30.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.81% | 41.12% | -24.31% |
FHLC vs. ARKG - Expense Ratio Comparison
FHLC has a 0.08% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Dividends
FHLC vs. ARKG - Dividend Comparison
FHLC's dividend yield for the trailing twelve months is around 1.43%, while ARKG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% | 0.00% | 0.00% |
FHLC Fidelity MSCI Health Care Index ETF | 1.43% | 1.40% | 1.51% | 1.40% | 1.30% | 1.16% | 1.45% | 1.18% | 1.38% | 1.38% | 1.40% | 2.07% |
Frequently Asked Questions
FHLC and ARKG have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (11.90%) compared to FHLC (4.05%). In terms of maximum drawdown, FHLC dropped -28.76% vs ARKG's -83.59%.
On 10-year performance, FHLC leads with 9.14% vs 7.22% for ARKG. On fees, FHLC is cheaper at 0.08% per year. On volatility, FHLC has been the lower-risk option at 4.05%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, FHLC has performed better with a 9.14% return vs 7.22%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FHLC is cheaper with a 0.08% expense ratio, compared with 0.75% for ARKG.
FHLC has the higher dividend yield at 1.43%, compared with 0.00% for ARKG.
They also come from different issuers: Fidelity and ARK. Their fees differ too: 0.08% for FHLC and 0.75% for ARKG.
ARKG currently has the higher Sharpe Ratio (1.31 vs 1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FHLC and ARKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer